ADAPT Data Linking Naproxen To Heart Risk Is “Not Reliable” – Nissen
This article was originally published in The Tan Sheet
Executive Summary
The premature halting of the ADAPT trial and subsequent safety concerns for naproxen were "inappropriate and reflected faulty logic," according to Cleveland Clinic cardiologist Steven Nissen, MD